Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...

After this test, you can get a Zepbound prescription if the healthcare professional thinks it is appropriate. Ro states that this whole process can take a week. PlushCare is another telehealth ...

When Jeanne began to seriously consider taking Zepbound, one of the new-generation weight-loss drugs, she had the briefest of ...

The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...

Eli Lilly forecast annual profit largely above Wall Street estimates on Thursday, a move investors said eases some concerns about signs of weakness in sales of its popular diabetes and weight-loss ...

The study lasts up to five weeks and involves four to five visits to the Center for Human Nutrition. The study involves measuring body composition, sleep, mood, diet and other aspects of health.

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

The drugmaker’s financial forecasts topped Wall Street’s expectations, reassuring investors after it overestimated demand for ...

Beyond Mounjaro and Zepbound, I'd encourage investors to take a serious look at Lilly's oncology business. Below, I'll explore how the company is quietly making significant strides in treating ...

"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...

Ready to take control of your journey ... guide or your healthcare provider for a full list of side effects. Zepbound is a GLP-1 agonist containing tirzepatide, the same active ingredient ...